" a Randomized Pilot Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation (ECMO-VA)."

NCT06602557 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia, Bacterial
Extracorporeal Membrane Oxygenation

Interventions

DRUG: Amikacin
DRUG: Standard of care

Sponsor

Assistance Publique - Hôpitaux de Paris